JeanMarie Guenot is the current president of Amphivena Therapeutics Inc., a company based in San Francisco that develops immune therapies for the treatment of cancer. She has been a business administrator for over 20 years in public and private sectors. She is also involved in commercial development, project management, pharmaceuticals R&D and venture capital. Through her company, Guenot LLC, she offers specialized consultation services like project management, licensing, commercial planning, mergers and acquisition, finance and alliance management services to biotechnology and pharmaceuticals companies.
LinkedIn shows that JeanMarie Guenot trained in Physical and medicinal chemistry and specialized in drug design, X-ray, quantum mechanical and semi-empirical methods, protein structure and prediction, NMR and refinement. She acquired her Ph.D. from the University of California in San Francisco and MBA from Wharton School, University of Pennsylvania. Her scientific career began at Hoffmann-La Roche as the principal scientist in preclinical R&D where she developed drugs for autoimmune diseases, inflammation, oncology and metabolic diseases. Her career in business started at Atlas Ventures as the manager of venture capital investments. Her noble achievement in this field was the creation of life science companies.
Before Jeanmarie became the president of Amphivena, as indicated by their leadership page, she had served in different companies in different roles. She served as the business consultant for Hoffmann in Basel and Shangai for one year between 2008- 2009. Before this she had also served as the vice-president of Corporate and Business Development at PDL BioPharma. Here, she played a dynamic role in facilitating the licensing, mergers and acquisitions and alliance management of R&D commercial product portfolios. She also led to a successful deal between PDL and Hoffmann- La Roche. This was a 50:50 deal where these companies were to collaborate in development and commercialization of their drugs. In acknowledgment of her efforts, she was awarded the BioBusiness Network Innovative Bio-Partnering Award in 2005 and Deal of Distinction in 2006 from Licensing Executive Society.
CrunchBase paints a picture that JeanMarie is highly experienced in leadership and management of large companies. Her hard work, integrity, and professional skills she demonstrates when conducting her duties, acts as an assurance that she will succeed.